X
19
Currax, based in U.S.A, is a pharmaceutical company.
One of their notable products is SUMATRIPTAN SUCCINATE, with a corresponding application number 206099.
Regulatory Information RX
With a dosage strength EQ 11MG BASE
Dosage Form Route POWDER; NASAL
Reference Listed Drug Yes
Approved since 2016-01-27